Cell & Developmental Biology
Open Access

Intrinsic and Extrinsic Apoptotic Pathways and Their Roles in Tissue Remodeling Immune Function and Pathological Conditions

Lars Jorgensen^{* *}Correspondence: Lars Jorgensen, Department of Immunology and Cell Biology, Scandinavian Institute of Life Sciences, Copenhagen, Denmark, Email:

Author info »

Description

Apoptosis is a highly regulated and energy-dependent process of programmed cell death that plays a critical role in maintaining tissue homeostasis, development, and defense against disease. Unlike necrosis, which is a form of uncontrolled cell death often associated with inflammation and cellular injury, apoptosis is a controlled and orderly process that allows cells to die without eliciting a damaging immune response. The precise regulation of apoptosis ensures that unwanted, damaged, or potentially harmful cells are eliminated while preserving the integrity of surrounding tissues. As such, apoptosis is essential for normal embryonic development, immune system function, and the prevention of diseases including cancer and autoimmune disorders [1].

Apoptotic processes are mediated through two primary pathways: the intrinsic pathway and the extrinsic pathway. The intrinsic pathway, also known as the mitochondrial pathway, is initiated in response to internal cellular stress signals, such as DNA damage, oxidative stress, or metabolic abnormalities. This pathway involves the permeabilization of the mitochondrial outer membrane and the subsequent release of cytochrome c into the cytoplasm. Cytochrome c interacts with apoptotic protease activating factor one to form the apoptosome, which activates caspase nine and, ultimately, executioner caspases such as caspase three and caspase seven. These caspases degrade critical cellular components, including cytoskeletal proteins and nuclear substrates, leading to characteristic morphological changes such as cell shrinkage, chromatin condensation, membrane blebbing, and formation of apoptotic bodies [2,3].

The extrinsic pathway, or death receptor pathway, is triggered by signals from the external cellular environment. Members of the tumor necrosis factor receptor superfamily, including Fas and tumor necrosis factor receptor one, bind to specific ligands on the cell surface and recruit adaptor proteins to form the deathinducing signaling complex. This complex activates initiator caspases, such as caspase eight, which then activate downstream executioner caspases, culminating in the dismantling of the cell. Cross-talk between the intrinsic and extrinsic pathways further amplifies the apoptotic response, ensuring that damaged or unnecessary cells are efficiently removed from tissues [4].

Apoptosis is tightly regulated by a balance between pro-apoptotic and anti-apoptotic factors. Members of the B cell lymphoma two protein family, including Bax and Bak, promote apoptosis by facilitating mitochondrial membrane permeabilization, whereas proteins such as B cell lymphoma two and B cell lymphoma extra-large inhibit apoptosis by maintaining mitochondrial integrity. The regulation of apoptosis extends to transcription factors, signaling pathways, and post-translational modifications that respond to cellular stress and survival signals. Dysregulation of these mechanisms can have profound pathological consequences, including uncontrolled cell proliferation in cancer, excessive cell loss in neurodegenerative diseases, or impaired immune responses [5,6].

In addition to its role in normal physiology, apoptosis is essential for development and tissue remodeling. During embryogenesis, apoptosis shapes organ formation, removes transient structures, and eliminates excess cells. In the immune system, apoptosis is crucial for the deletion of autoreactive lymphocytes, ensuring self-tolerance and preventing autoimmune disease. Similarly, the controlled death of infected or damaged cells during viral infection or tissue injury limits the spread of pathogens and facilitates tissue repair. Apoptosis is also instrumental in maintaining the balance between cell proliferation and cell death in adult tissues, allowing organisms to adapt to environmental changes and physiological demands [7].

Apoptotic cells are efficiently recognized and cleared by phagocytic cells such as macrophages and dendritic cells, preventing the release of intracellular contents that could trigger inflammation. "Eat me" signals, including the exposure of phosphatidylserine on the outer leaflet of the plasma membrane, mediate the recognition and engulfment of apoptotic bodies. This process of immunologically silent clearance distinguishes apoptosis from necrosis and contributes to the resolution of inflammation and tissue homeostasis [8].

Research into apoptosis has advanced the development of therapeutic strategies for a variety of diseases. In cancer, therapies that reactivate apoptotic pathways in tumor cells, such as small molecule inhibitors of anti-apoptotic B cell lymphoma two proteins, aim to selectively induce cancer cell death. In contrast, preventing inappropriate apoptosis may benefit conditions characterized by excessive cell loss, such as neurodegenerative diseases, myocardial infarction, and stroke. Understanding the molecular mechanisms of apoptosis, including caspase activation, mitochondrial dynamics, and death receptor signaling, continues to provide insights into disease pathogenesis and inform the design of novel medical interventions [9,10].

Conclusion

In conclusion, apoptosis is a highly regulated process of programmed cell death that ensures the removal of damaged, unnecessary, or potentially harmful cells in a controlled manner. Through intrinsic and extrinsic pathways, and tightly coordinated regulatory networks, apoptosis maintains tissue homeostasis, supports development, and prevents disease. The study of apoptosis not only enhances understanding of fundamental cellular processes but also offers opportunities for therapeutic innovation in cancer, immune disorders, neurodegeneration, and regenerative medicine. Continued research in apoptotic mechanisms promises to reveal further insights into cellular survival, death, and the maintenance of physiological balance.

References

1. Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Apoptosis and Beyond: Cytometry in studies of programmed cell death. Methods Cell Biol. 2011;103:55.

   [Crossref] [Google Scholar] [PubMed]

2. Kim JW, Choi EJ, Joe CO. Activation of Death-Inducing Signaling Complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene. 2000;9:4491-4499. 

   [Crossref] [Google Scholar] [PubMed]

3. Nuñez G, Benedict M A, Hu Y, Inohara N. Caspases: The proteases of the apoptotic pathway. Oncogene. 1998;17:3237-3245.

   [Crossref] [Google Scholar] [PubMed]

4. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol. 2007;3:495-516.

   [Crossref] [Google Scholar] [PubMed]

5. Ameisen JC. On the origin, evolution, and nature of programmed cell death: A timeline of four billion years. Cell Death Differ. 2002;9:367-393.

   [Crossref] [Google Scholar] [PubMed]

6. Letai A. Growth factor withdrawal and apoptosis: The middle game. Mol Cell. 2006;21:728-730.

   [Crossref] [Google Scholar] [PubMed]

7. Slikker Jr W, Paule MG, Wang C. Handbook of developmental neurotoxicology. Academic Press. 2018. 

   [Crossref] [Google Scholar]

8. Liu ZG, Jiao D. Necroptosis. Tumor necrosis and tumorigenesis. Cell Stress. 2020;4:1.

   [Crossref] [Google Scholar] [PubMed]

9. Dhuriya YK, Sharma D. Necroptosis: A regulated inflammatory mode of cell death. J Neuroinflamm. 2018;15:199.

   [Crossref] [Google Scholar] [PubMed]

10. Jan R, Chaudhry GeS. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull. 2019;9:205.

    [Crossref] [Google Scholar] [PubMed]